The role of CREBBP/EP300 and its therapeutic implications in hematological malignancies

Y Zhu, Z Wang, Y Li, H Peng, J Liu, J Zhang, X Xiao - Cancers, 2023 - mdpi.com
Simple Summary Through their regulatory effects on gene expression, histone
acetyltransferases have been implicated in the normal physiological activities and genesis …

Transcription factor abnormalities in B-ALL leukemogenesis and treatment

H Yin, J Wang, Y Tan, M Jiang, H Zhang, G Meng - Trends in Cancer, 2023 - cell.com
The biological regulation of transcription factors (TFs) and repressor proteins is an important
mechanism for maintaining cell homeostasis. In B cell acute lymphoblastic leukemia (B-ALL) …

BAHCC1 binds H3K27me3 via a conserved BAH module to mediate gene silencing and oncogenesis

H Fan, J Lu, Y Guo, D Li, ZM Zhang, YH Tsai, WC Pi… - Nature …, 2020 - nature.com
Trimethylated histone H3 lysine 27 (H3K27me3) regulates gene repression, cell-fate
determination and differentiation. We report that a conserved bromo-adjacent homology …

1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma

TS Johnson, P Sudha, E Liu, N Becker… - Nature …, 2024 - nature.com
Multiple Myeloma is an incurable plasma cell malignancy with a poor survival rate that is
usually treated with immunomodulatory drugs (iMiDs) and proteosome inhibitors (PIs). The …

Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial–Mesenchymal Transition

KT Chuang, SS Chiou, SH Hsu - Cancers, 2023 - mdpi.com
Simple Summary The study discusses the potential of targeting transcription factors (TFs) for
cancer therapy and provide a systematic classification of various types of TFs involved in the …

USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer

YT Huang, AC Cheng, HC Tang, GC Huang… - Cell Death & …, 2021 - nature.com
USP7, one of the most abundant ubiquitin-specific proteases (USP), plays multifaceted roles
in many cellular events, including oncogenic pathways. Accumulated studies have …

Mediator subunit MED1 is required for E2A-PBX1–mediated oncogenic transcription and leukemic cell growth

YL Lee, K Ito, WC Pi, IH Lin, CS Chu… - Proceedings of the …, 2021 - National Acad Sciences
The chimeric transcription factor E2A-PBX1, containing the N-terminal activation domains of
E2A fused to the C-terminal DNA-binding domain of PBX1, results in 5% of pediatric acute …

P2X1 enhances leukemogenesis through PBX3-BCAT1 pathways

X He, Y Xu, D Huang, Z Yu, J Yu, L Xie, L Liu, Y Yu… - Leukemia, 2023 - nature.com
How bone marrow niches regulate leukemogenic activities of leukemia-initiating cells (LICs)
is unclear. The present study revealed that the metabolic niche component, ATP, efficiently …

The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A‐PBX1: a 10‐year retrospective study

B Zhou, X Chu, H Tian, T Liu, H Liu… - American Journal of …, 2021 - Wiley Online Library
The clinical outcomes and genomic features of E2A‐PBX1 (TCF3‐PBX1)‐positive B‐cell
acute lymphoblastic leukemia (B‐ALL) patients remain unclear. A total of 137 patients …

TAF2, within the TFIID complex, regulates the expression of a subset of protein-coding genes

IH Cheng, WC Pi, CH Hsu, Y Guo, JL Lai… - Cell Death …, 2024 - nature.com
TFIID, one of the general transcription factor (GTF), regulates transcriptional initiation of
protein-coding genes through direct binding to promoter elements and subsequent …